766 NEW ZEALAND GAZETTE, No. 32 3 FEBRUARY 2005

Product:
Fluconazole
Active Ingredient:
Fluconazole 150mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada

Product:
Fluconazole
Active Ingredient:
Fluconazole 200mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada

Product:
Fluconazole
Active Ingredient:
Fluconazole 50mg
Dosage Form:
Capsule
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Genpharm Inc., Etobicoke, Ontario, Canada

Product:
Lorfast
Active Ingredient:
Loratadine 1mg/mL
Dosage Form:
Syrup
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Kleva Limited, Athens, Greece

Dated this 29th day of January 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go585

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule
Product:
Macleans Extreme Clean
Active Ingredient:
Sodium fluoride 0.221%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia

Dated this 29th day of January 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go586

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981, I, Don Matheson, Deputy Director-General, Public Health Directorate, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1
Prescription Medicines
Acepromazine
Adalimumab
Adefovir
Adenosine; for injection
Alefacept
Amethocaine; for internal use; for external use in medicines containing more than 10%; for ophthalmic use except when used in practice by a registered optometrist
Amygdalin; at all strengths
Amylocaine
Aprepitant
Aripiprazole